Palisade Capital Management’s Evolus EOLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-38,016
Closed -$158K 393
2020
Q1
$158K Buy
38,016
+2,000
+6% +$16.9K 0.01% 408
2019
Q4
$438K Buy
36,016
+5,016
+16% +$70.7K 0.01% 360
2019
Q3
$484K Sell
31,000
-5,700
-16% -$93.4K 0.01% 364
2019
Q2
$537K Buy
+36,700
New +$727K 0.02% 359

Other funds holding EOLS

Palisade Capital Management's EOLS Position: Q2 2020 in Review

Palisade Capital Management sold out of Evolus (EOLS) in Q2 2020, closing a stake of 38,016 shares — an estimated $158K sold.

Palisade Capital Management first reported a position in EOLS in Q2 2019 and held it in 4 quarters. The position peaked at $537K in Q2 2019. 90 funds tracked by Wall St. Rank hold EOLS as of Q2 2020.

  • Palisade Capital Management reported no remaining Evolus position as of Q2 2020 after selling out during the quarter.
  • Palisade Capital Management sold 38,016 Evolus shares in Q2 2020, an estimated $158K.
  • Palisade Capital Management first reported a position in Evolus in Q2 2019 and held it in 4 quarters.
  • Palisade Capital Management's Evolus position peaked at $537K in Q2 2019.
  • 90 funds tracked by Wall St. Rank held Evolus as of Q2 2020.

Based on Palisade Capital Management's 13F filing for Q2 2020, filed 6 Aug 2020.